HUP0003931A2 - Vitronektin receptor antagonisták, valamint a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents

Vitronektin receptor antagonisták, valamint a vegyületeket tartalmazó gyógyszerkészítmények Download PDF

Info

Publication number
HUP0003931A2
HUP0003931A2 HU0003931A HUP0003931A HUP0003931A2 HU P0003931 A2 HUP0003931 A2 HU P0003931A2 HU 0003931 A HU0003931 A HU 0003931A HU P0003931 A HUP0003931 A HU P0003931A HU P0003931 A2 HUP0003931 A2 HU P0003931A2
Authority
HU
Hungary
Prior art keywords
compound according
compound
treatment
cells
preparation
Prior art date
Application number
HU0003931A
Other languages
English (en)
Hungarian (hu)
Inventor
William H. Miller
Original Assignee
Smithkline Beecham Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp. filed Critical Smithkline Beecham Corp.
Publication of HUP0003931A2 publication Critical patent/HUP0003931A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0003931A 1997-09-24 1998-09-24 Vitronektin receptor antagonisták, valamint a vegyületeket tartalmazó gyógyszerkészítmények HUP0003931A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5986797P 1997-09-24 1997-09-24
PCT/US1998/019987 WO1999015178A1 (fr) 1997-09-24 1998-09-24 Antagoniste du recepteur de la vitronectine

Publications (1)

Publication Number Publication Date
HUP0003931A2 true HUP0003931A2 (hu) 2001-10-28

Family

ID=22025805

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003931A HUP0003931A2 (hu) 1997-09-24 1998-09-24 Vitronektin receptor antagonisták, valamint a vegyületeket tartalmazó gyógyszerkészítmények

Country Status (13)

Country Link
EP (1) EP1023073A1 (fr)
JP (1) JP2002500162A (fr)
KR (1) KR20010024249A (fr)
CN (1) CN1271284A (fr)
AU (1) AU9578798A (fr)
BR (1) BR9813214A (fr)
CA (1) CA2304000A1 (fr)
HU (1) HUP0003931A2 (fr)
IL (1) IL135188A0 (fr)
NO (1) NO20001515D0 (fr)
PL (1) PL339414A1 (fr)
TR (1) TR200000786T2 (fr)
WO (1) WO1999015178A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1150965A4 (fr) 1999-02-03 2002-05-15 Merck & Co Inc Derives de la benzazepine utilises comme antagonistes du recepteur alpha-v de l'integrine
US6514964B1 (en) 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
CN1247258C (zh) 2001-04-24 2006-03-29 默克专利有限公司 使用抗血管生成剂和TNFα的联合疗法
KR20040058229A (ko) 2001-10-22 2004-07-03 더 스크립스 리서치 인스티튜트 항체 표적화 화합물
WO2004089890A2 (fr) * 2003-04-04 2004-10-21 Smithkline Beecham Corporation Procede et produits intermediaires pour preparer des benzazepines
ATE420188T1 (de) 2004-02-02 2009-01-15 Pioneer Hi Bred Int Ap2-domäne-transkriptionsfaktor odp2 (ovule development protein 2) und verwendungsverfahren
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
KR20080089489A (ko) 2006-01-18 2008-10-06 메르크 파텐트 게엠베하 인테그린 리간드를 사용하는 암치료용 특이적 요법
EA017864B1 (ru) 2007-01-18 2013-03-29 Мерк Патент Гмбх Специфическая терапия и лекарственное средство на основе интегриновых лигандов для лечения рака
EP2221308B1 (fr) 2007-11-16 2013-07-10 Ube Industries, Ltd. Composé de benzazépinone
US8076475B2 (en) * 2008-03-06 2011-12-13 Glaxosmithkline Llc Process
JP2012517447A (ja) 2009-02-10 2012-08-02 ザ スクリプス リサーチ インスティチュート 化学的にプログラムされたワクチン接種法
EP2415474B1 (fr) 2009-03-30 2013-08-28 Ube Industries, Ltd. Composition pharmaceutique pour la prévention ou le traitement de maladies ophtalmiques
AU2010252280A1 (en) 2009-05-25 2012-01-19 Merck Patent Gmbh Continuous administration of cilengitide in cancer treatments
CA2793596A1 (fr) 2009-12-30 2011-07-07 Pioneer Hi-Bred International, Inc. Procedes et compositions pour la modification ciblee de polynucleotides
CA2793600C (fr) 2009-12-30 2020-01-14 Pioneer Hi-Bred International, Inc. Procedes et compositions pour l'introduction et l'expression regulee de genes dans des plantes
ES2864079T3 (es) 2014-05-30 2021-10-13 Pfizer Derivados de carbonitrilo como moduladores selectivos del receptor de andrógenos
WO2023275715A1 (fr) 2021-06-30 2023-01-05 Pfizer Inc. Métabolites de modulateurs sélectifs du récepteur des androgènes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60311C2 (uk) * 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція

Also Published As

Publication number Publication date
TR200000786T2 (tr) 2000-08-21
KR20010024249A (ko) 2001-03-26
AU9578798A (en) 1999-04-12
PL339414A1 (en) 2000-12-18
CN1271284A (zh) 2000-10-25
WO1999015178A1 (fr) 1999-04-01
NO20001515L (no) 2000-03-23
IL135188A0 (en) 2001-05-20
BR9813214A (pt) 2000-08-29
EP1023073A1 (fr) 2000-08-02
NO20001515D0 (no) 2000-03-23
JP2002500162A (ja) 2002-01-08
CA2304000A1 (fr) 1999-04-01

Similar Documents

Publication Publication Date Title
JP4491072B2 (ja) ビトロネクチンレセプター拮抗物質
HUP0003949A2 (hu) Vitronektin receptor antagonisták, valamint a vegyületeket tartalmazó gyógyszerkészítmények
HUP0001945A2 (hu) Vitronektin receptor antagonista hatású dibanzociklohepténszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
KR20010024249A (ko) 비트로넥틴 수용체 길항제
HUP0003641A2 (en) Dibenzocycloheptene derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical compositions containing them
HUP0104804A2 (hu) Tetrahidro-naftiridinil-származék, mint vitronektin receptor antagonista, eljárás előállítására és ezt tartalmazó gyógyszerkészítmény
HUP0103090A2 (hu) Vitronektin receptor antagonista oxazolszármazékok, eljárás az előállításukra, a vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
US20020019387A1 (en) Vitronectin receptor antagonist
US20010014737A1 (en) Vitronectin receptor antagonist
MXPA00002895A (en) Vitronectin receptor antagonist
CZ20001061A3 (cs) Antagonista receptoru pro vitronektin
MXPA00002896A (en) Vitronectin receptor antagonist
MXPA01001386A (en) Vitronectin receptor antagonists
CZ20001060A3 (cs) Antagonista receptoru vitronektinu
CZ2000979A3 (cs) Antagonista vitronektinového receptoru